We are live on ! Find out more
TMO icon

Thermo Fisher Scientific

2,266 hedge funds and large institutions have $176B invested in Thermo Fisher Scientific in 2022 Q3 according to their latest regulatory filings, with 116 funds opening new positions, 927 increasing their positions, 863 reducing their positions, and 102 closing their positions.

New
Increased
Maintained
Reduced
Closed

14% more first-time investments, than exits

New positions opened: 116 | Existing positions closed: 102

13% more call options, than puts

Call options by funds: $1.47B | Put options by funds: $1.3B

7% more repeat investments, than reductions

Existing positions increased: 927 | Existing positions reduced: 863

0.97% more ownership

Funds ownership: 87.64%88.62% (+0.97%)

1% less funds holding

Funds holding: 2,2812,266 (-15)

5% less capital invested

Capital invested by funds: $186B → $176B (-$9.79B)

6% less funds holding in top 10

Funds holding in top 10: 253238 (-15)

Holders
2,266
Holders Change
-15
Holders Change %
-0.66%
% of All Funds
39.04%
Holding in Top 10
238
Holding in Top 10 Change
-15
Holding in Top 10 Change %
-5.93%
% of All Funds
4.1%
New
116
Increased
927
Reduced
863
Closed
102
Calls
$1.47B
Puts
$1.3B
Net Calls
+$166M
Net Calls Change
+$177M
Name Holding Trade Value Shares
Change
Change in
Stake
BSW
951
Buckingham Strategic Wealth
Missouri
$3.13M +$154K +276 +5%
CAM
952
Congress Asset Management
Massachusetts
$3.12M -$494K -883 -13%
AAMU
953
AEGON Asset Management (UK)
United Kingdom
$3.11M -$213K -380 -6%
CSS
954
Cubist Systematic Strategies
Connecticut
$3.1M -$1.89M -3,370 -36%
ST
955
Smithfield Trust
Pennsylvania
$3.1M +$12.3K +22 +0.4%
MC
956
Middleton & Co
Massachusetts
$3.1M -$3.12M -5,571 -48%
Group One Trading
957
Group One Trading
Illinois
$3.09M -$7.15M -12,782 -68%
FMII
958
Farmers & Merchants Investments Inc
Nebraska
$3.09M +$2.8K +5 +0.1%
SC
959
Slow Capital
California
$3.08M +$182K +325 +6%
RSVP
960
Ramsay Stattman Vela & Price
Colorado
$3.08M
CPIA
961
Cornell Pochily Investment Advisors
New York
$3.08M -$36.4K -65 -1%
BP
962
Ballentine Partners
Massachusetts
$3.08M +$326K +582 +11%
KIC
963
Keating Investment Counselors
Florida
$3.06M -$36.4K -65 -1%
SG Americas Securities
964
SG Americas Securities
New York
$3.05M -$4.3M -7,682 -56%
NSEDCP
965
NJ State Employees Deferred Compensation Plan
New Jersey
$3.04M
FMWA
966
Forvis Mazars Wealth Advisors
Missouri
$3.04M +$123K +219 +4%
BFG
967
Berger Financial Group
Minnesota
$3.03M -$37.5K -67 -1%
APWM
968
Atlas Private Wealth Management
New York
$3.03M +$70.5K +126 +2%
CWM
969
CIBC World Markets
New York
$3.02M -$12M -21,383 -78%
MIC
970
MU Investments Company
Japan
$2.99M
GIA
971
Gladstone Institutional Advisory
Florida
$2.98M +$1.78M +3,189 +119%
BPCA
972
Bank Pictet & Cie (Asia)
Singapore
$2.98M -$539K -963 -14%
LNC
973
Lincoln National Corp
Pennsylvania
$2.97M +$226K +403 +7%
SAM
974
Security Asset Management
New York
$2.97M +$354K +633 +12%
ICG
975
InterOcean Capital Group
Tennessee
$2.97M +$377K +674 +13%

TMO Hedge Fund Activity: Q3 2022 in Review

2,266 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Thermo Fisher Scientific (TMO) for Q3 2022, worth a combined $176B — down 5.3% from $186B a quarter earlier.

Buyers outnumbered sellers: 116 funds opened new TMO positions and 102 closed out — a net gain of 14 holders — while 927 added to existing stakes and 863 trimmed.

The largest buyer was Janus Henderson Group, adding an estimated $795M. The largest seller was T. Rowe Price Associates, cutting an estimated $2.12B.

  • 2,266 institutional investors held Thermo Fisher Scientific (TMO) as of Q3 2022, down from 2,281 in Q2 2022.
  • Funds reported $176B of Thermo Fisher Scientific stock for Q3 2022, down 5.3% quarter-over-quarter.
  • 116 funds opened new Thermo Fisher Scientific positions in Q3 2022 and 102 closed out, a net change of +14 holders.
  • The largest Thermo Fisher Scientific buyer in Q3 2022 was Janus Henderson Group, an estimated $795M added.
  • The largest Thermo Fisher Scientific seller in Q3 2022 was T. Rowe Price Associates, an estimated $2.12B sold.

Based on aggregated 13F filings for Q3 2022.